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Objectives
T h el i f ee x p e c t a n c yo fH I Vpositive individuals has
improved dramatically with the advent of HAART. The
cohort of older people living with HIV is steadily
increasing in size. Both advancing age and HIV are asso-
ciated with an increased likelihood of comorbidities and
polypharmacy independently, but little is known about
their combined impact and how this will shape the care
required from HIV physicians. This study was designed
to gain insight into the characteristics of patients aged
60 or over living with HIV.
Methods
Data was collected from 5 centres across England and
Wales. All patients currently aged 60 or over were
included. A questionnaire format was used to collect
information on demographics, risk factors for infection,
co-morbidities, co-infections, all medicine use including
HAART and resistance patterns.
Results
There were 66 patients in total. 79% of these patients
were male. Half of the patients were MSM. 76% were
Caucasian, 12% Black African, 8% Black Caribbean and
3% Asian. The current age range was 60 to 79 years,
with a mode and median age of 62 and 64 years respec-
tively. The age of diagnosis ranged from 39 to 71, with a
median age of 59 years. Almost half of the patients were
diagnosed at age 60 or over. The duration of HIV infec-
tion ranged from 2 months to 22 years with 48% of
patients having been diagnosed within the last 5 years.
This supports a combination of patients living to older
ages with HIV and acquisition of HIV in later life. 53%
had a CD4 count of less than 200 at diagnosis. 38% had
had an AIDS defining condition. Only 7% had a CD4
count of <200cells/mm
3 in 2010. 84% had one or more
comorbidity. 31% had 3 or more comorbidities. 92% of
patients were on HAART. Of those on treatment, 86%
had current viral loads of <50 copies/ml. Of the 5
patients who were not on treatment, all were between
the age of 60 and 65 currently, diagnosed within the last
4 years and had CD4 counts over 450cells/mm
3.8 9 %o f
patients were on 1 or more prescribed medication, in
addition to HAART or septrin. 23% were on 5 or more
medications.
Conclusions
This data provides an insight into an ever growing
cohort of older people with HIV, in whom there is a
paucity of information. It gives some information on the
risk factors, comorbidities, stage of infection at diagnosis
and response to treatment. In this cohort, despite the
complexities associated with managing HIV in older
patients, the majority of patients were fully suppressed
with good CD4 counts.
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